期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 23, 页码 -出版社
MDPI
DOI: 10.3390/ijms222312980
关键词
bacteria; bacterial toxins; lung cancer; proteomics; extracellular vesicles
资金
- Juraj Dobrila University of Pula [A01 00 78, A01 00 77]
- European Regional Development Fund ERDF [KK.01.2.1.02.0289]
Bacteria and their toxins show potential in cancer therapy, but also have limitations. Proteomics plays a crucial role in studying bacterial toxins, contributing to the development of anticancer drugs based on bacterial toxins. Bacterial extracellular vesicles, as a new application in immunotherapy, are an area of growing interest.
Cancer is one of the most important global health problems that continues to demand new treatment strategies. Many bacteria that cause persistent infections play a role in carcinogenesis. However, since bacteria are well studied in terms of molecular mechanisms, they have been proposed as an interesting solution to treat cancer. In this review, we present the use of bacteria, and particularly bacterial toxins, in cancer therapy, highlighting the advantages and limitations of bacterial toxins. Proteomics, as one of the omics disciplines, is essential for the study of bacterial toxins. Advances in proteomics have contributed to better characterization of bacterial toxins, but also to the development of anticancer drugs based on bacterial toxins. In addition, we highlight the current state of knowledge in the rapidly developing field of bacterial extracellular vesicles, with a focus on their recent application as immunotherapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据